The DOI matches its Crossref record; 483 of the 483 references it cites were found in a registry or an index.
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Open accessAbstract
BACKGROUND: Omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3)), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid (ALA)) may benefit cardiovascular health. Guidelines recommend increasing omega-3-rich foods, and sometimes supplementation, but recent trials have not confirmed this. OBJECTIVES: To assess the effects of increased intake of fish- and plant-based omega-3 fats for all-cause mortality, cardiovascular events, adiposity and lipids. SEARCH METHODS: We searched CENTRAL, MEDLINE and Embase to February 2019, plus ClinicalTrials.gov and World Health Organization International Clinical Trials Registry to August 2019, with no language restrictions. We handsearched systematic review references and bibliographies and contacted trial authors. SELECTION CRITERIA: We included randomised controlled trials (RCTs) that lasted at least 12 months and compared supplementation or advice to increase LCn3 or ALA intake, or both, versus usual or lower intake. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion, extracted data and assessed validity. We performed separate random-effects meta-analysis for ALA and LCn3 interventions, and assessed dose-response relationships through meta-regression. MAIN RESULTS: We included 86 RCTs (162,796 participants) in this review update and found that 28 were at low summary risk of bias. Trials were of 12 to 88 months' duration and included adults at varying cardiovascular risk, mainly in high-income countries. Most trials assessed LCn3 supplementation with capsules, but some used LCn3- or ALA-rich or enriched foods or dietary advice compared to placebo or usual diet. LCn3 doses ranged from 0.5 g a day to more than 5 g a day (19 RCTs gave at least 3 g LCn3 daily). Meta-analysis and sensitivity analyses suggested little or no effect of increasing LCn3 on all-cause mortality (risk ratio (RR) 0.97, 95% confidence interval (CI) 0.93 to 1.01; 143,693 participants; 11,297 deaths in 45 RCTs; high-certainty evidence), cardiovascular mortality (RR 0.92, 95% CI 0.86 to 0.99; 117,837 participants; 5658 deaths in 29 RCTs; moderate-certainty evidence), cardiovascular events (RR 0.96, 95% CI 0.92 to 1.01; 140,482 participants; 17,619 people experienced events in 43 RCTs; high-certainty evidence), stroke (RR 1.02, 95% CI 0.94 to 1.12; 138,888 participants; 2850 strokes in 31 RCTs; moderate-certainty evidence) or arrhythmia (RR 0.99, 95% CI 0.92 to 1.06; 77,990 participants; 4586 people experienced arrhythmia in 30 RCTs; low-certainty evidence). Increasing LCn3 may slightly reduce coronary heart disease mortality (number needed to treat for an additional beneficial outcome (NNTB) 334, RR 0.90, 95% CI 0.81 to 1.00; 127,378 participants; 3598 coronary heart disease deaths in 24 RCTs, low-certainty evidence) and coronary heart disease events (NNTB 167, RR 0.91, 95% CI 0.85 to 0.97; 134,116 participants; 8791 people experienced coronary heart disease events in 32 RCTs, low-certainty evidence). Overall, effects did not differ by trial duration or LCn3 dose in pre-planned subgrouping or meta-regression. There is little evidence of effects of eating fish. Increasing ALA intake probably makes little or no difference to all-cause mortality (RR 1.01, 95% CI 0.84 to 1.20; 19,327 participants; 459 deaths in 5 RCTs, moderate-certainty evidence),cardiovascular mortality (RR 0.96, 95% CI 0.74 to 1.25; 18,619 participants; 219 cardiovascular deaths in 4 RCTs; moderate-certainty evidence), coronary heart disease mortality (RR 0.95, 95% CI 0.72 to 1.26; 18,353 participants; 193 coronary heart disease deaths in 3 RCTs; moderate-certainty evidence) and coronary heart disease events (RR 1.00, 95% CI 0.82 to 1.22; 19,061 participants; 397 coronary heart disease events in 4 RCTs; low-certainty evidence). However, increased ALA may slightly reduce risk of cardiovascular disease events (NNTB 500, RR 0.95, 95% CI 0.83 to 1.07; but RR 0.91, 95% CI 0.79 to 1.04 in RCTs at low summary risk of bias; 19,327 participants; 884 cardiovascular disease events in 5 RCTs; low-certainty evidence), and probably slightly reduces risk of arrhythmia (NNTB 91, RR 0.73, 95% CI 0.55 to 0.97; 4912 participants; 173 events in 2 RCTs; moderate-certainty evidence). Effects on stroke are unclear. Increasing LCn3 and ALA had little or no effect on serious adverse events, adiposity, lipids and blood pressure, except increasing LCn3 reduced triglycerides by ˜15% in a dose-dependent way (high-certainty evidence). AUTHORS' CONCLUSIONS: This is the most extensive systematic assessment of effects of omega-3 fats on cardiovascular health to date. Moderate- and low-certainty evidence suggests that increasing LCn3 slightly reduces risk of coronary heart disease mortality and events, and reduces serum triglycerides (evidence mainly from supplement trials). Increasing ALA slightly reduces risk of cardiovascular events and arrhythm
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Markers in COPD
Matsuyama, W., Mitsuyama, H., Watanabe, M., Oonakahara, K.-I., Higashimoto, I., Osame, M., & Arimura, K. (2005) · Chest · doi:10.1378/chest.128.6.3817 · Cited by 108
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538 · cited 1×
“Lack of blinding is associated with bias, though smaller levels of bias than lack of allocation concealment (Savovic 2012), especially in studies with objectively measured outcomes (Wood 2008), such as those we primarily used in our review.”
BackgroundYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J. L., Guidollet, J., Touboul, P., & Delaye, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92580-1 · Cited by 2,122
(1999) · PubMed · Cited by 2,062
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA · doi:10.1001/2012.jama.11374 · Cited by 960
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 944
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 879
Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., Bories, L., Cufi, M.-N., Dantoine, T., Dartigues, J.-F., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30040-6 · Cited by 838
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease
Belluzzi, A., Brignola, C., Campieri, M., Pera, A., Boschi, S., & Miglioli, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342401 · Cited by 766
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial
Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., Galvin, J. E., Emond, J., Jack, C. R., Weiner, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1510 · Cited by 764
心筋梗塞後のn-3多価不飽和脂肪酸とビタミンEの食事補給:GISSI-Prevenzione試験の結果
Marchioli, R., Valagussa, F., Franzosi, M. G., Geraci, E., Mininni, N., Nicolosi, G. L., Santini, M., Tavazzi, L., & Vecchio, C. (1999) · The Lancet · Cited by 707
Reduction in saturated fat intake for cardiovascular disease
Hooper, L., Martin, N., Abdelhamid, A., & Davey Smith, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011737 · Cited by 704
Self-citationEffects of n−3 Fatty Acid Supplements in Diabetes Mellitus
The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804989 · Cited by 698
Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., et al. (2006) · BMJ · doi:10.1136/bmj.38755.366331.2f · Cited by 676
Self-citationSavović, J., Jones, H., Altman, D., Harris, R., Jűni, P., Pildal, J., Als-Nielsen, B., Balk, E., Gluud, C., Gluud, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16350 · Cited by 668
Singh, R. B., Dubnov, G., Niaz, M. A., Ghosh, S., Singh, R., Rastogi, S. S., Manor, O., Pella, D., & Berry, E. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11472-3 · Cited by 663 · cited 1×
“We initially included several studies into our wider data set (Singh 1992; Singh 1997a; Singh 1997b; Singh 2002), but we later excluded them due to expressions of concern published by the BMJ and The Lancet (BMJ 2005; Horton 2005; White 2005).”
ResultKatan, M. B., Deslypere, J. P., van Birgelen, A. P., Penders, M., & Zegwaard, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37132-7 · Cited by 638
Aung, T., Halsey, J., Kromhout, D., Gerstein, H. C., Marchioli, R., Tavazzi, L., Geleijnse, J. M., Rauch, B., Ness, A., Galan, P., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5205 · Cited by 632
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
Physiological compartmental analysis of α-linolenic acid metabolism in adult humans
Pawlosky, R. J., Hibbeln, J. R., Novotny, J. A., & Salem, N. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31576-5 · Cited by 592
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
PLASMA LIPIDS AND LIPOPROTEINS IN GREENLANDIC WEST COAST ESKIMOS
Bang, H. O., & Dyerberg, J. (1972) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1972.tb04782.x · Cited by 563
Manson, J. E., Bassuk, S. S., Lee, I.-M., Cook, N. R., Albert, M. A., Gordon, D., Zaharris, E., MacFadyen, J. G., Danielson, E., Lin, J., et al. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.09.009 · Cited by 557
Singh, R. B., Niaz, M. A., Sharma, J. P., Kumar, R., Rastogi, V., & Moshiri, M. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007757724505 · Cited by 536
Stark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.05.001 · Cited by 519
Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510
von Schacky, C., Angerer, P., Kothny, W., Theisen, K., & Mudra, H. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00003 · Cited by 487
ABSENCE OF CROSS-REACTIVITY BETWEEN CAPTOPRIL AND ENALAPRIL
Navis, G. J., De Jong, P. E., Kallenberg, C. G. M., De Monchy, J., & De Zeeuw, D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92353-5 · Cited by 485
Singh, R. B., Rastogi, S. S., Verma, R., Laxmi, B., Singh, R., Ghosh, S., & Niaz, M. A. (1992) · BMJ · doi:10.1136/bmj.304.6833.1015 · Cited by 458
The Oslo Diet-Heart Study: Eleven-Year Report
LEREN, P. (1970) · Circulation · doi:10.1161/01.cir.42.5.935 · Cited by 458
Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7376 · Cited by 415
The Age-related Eye Disease Study 2 (AREDS2)
Chew, E. Y., Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., Sperduto, R., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.05.027 · Cited by 415
Lack of benefit of dietary advice to men with angina: results of a controlled trial
Burr, M. L., Ashfield-Watt, P. A. L., Dunstan, F. D. J., Fehily, A. M., Breay, P., Ashton, T., Zotos, P. C., Haboubi, N. A. A., & Elwood, P. C. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601539 · Cited by 409
A Controlled Trial of Fish Oil in IgA Nephropathy
Donadio, J. V., Bergstralh, E. J., Offord, K. P., Spencer, D. C., & Holley, K. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311804 · Cited by 408
Assessing risk of bias due to missing results in a synthesis
Page, M. J., Higgins, J. P., & Sterne, J. A. (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch13 · Cited by 402
Hu, Y., Hu, F. B., & Manson, J. E. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013543 · Cited by 388
Chowdhury, R., Stevens, S., Gorman, D., Pan, A., Warnakula, S., Chowdhury, S., Ward, H., Johnson, L., Crowe, F., Hu, F. B., et al. (2012) · BMJ · doi:10.1136/bmj.e6698 · Cited by 379
Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2884 · Cited by 371
Kwak (2012) · doi:10.1001/archinternmed.2012.262 · Cited by 368
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Boucher, P., & Mamelle, N. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1181 · Cited by 365
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake
Leaf, A., Albert, C. M., Josephson, M., Steinhaus, D., Kluger, J., Kang, J. X., Cox, B., Zhang, H., & Schoenfeld, D. (2005) · Circulation · doi:10.1161/circulationaha.105.549527 · Cited by 364
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review
Delgado-Lista, J., Perez-Martinez, P., Lopez-Miranda, J., & Perez-Jimenez, F. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001596 · Cited by 351
Cretan Mediterranean diet for prevention of coronary heart disease
Renaud, S., de Lorgeril, M., Delaye, J., Guidollet, J., Jacquard, F., Mamelle, N., Martin, J., Monjaud, I., Salen, P., & Toubol, P. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1360s · Cited by 340
Cleland, J. G. F., Freemantle, N., Coletta, A. P., & Clark, A. L. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.12.003 · Cited by 320
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316
Browning, L. M., Walker, C. G., Mander, A. P., West, A. L., Madden, J., Gambell, J. M., Young, S., Wang, L., Jebb, S. A., & Calder, P. C. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.041343 · Cited by 314
Brown, T. J., Brainard, J., Song, F., Wang, X., Abdelhamid, A., & Hooper, L. (2019) · BMJ · doi:10.1136/bmj.l4697 · Cited by 313
Self-citationGogos, C. A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N. C., & Kalfarentzos, F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<403::aid-cncr21>3.0.co;2-1 · Cited by 311
Scorletti, E., Bhatia, L., McCormick, K. G., Clough, G. F., Nash, K., Hodson, L., Moyses, H. E., Calder, P. C., Byrne, C. D., Sheron, N., et al. (2014) · Hepatology · doi:10.1002/hep.27289 · Cited by 310
Sanyal, A. J., Abdelmalek, M. F., Suzuki, A., Cummings, O. W., & Chojkier, M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.046 · Cited by 309
Hawthorne, A. B., Daneshmend, T. K., Hawkey, C. J., Belluzzi, A., Everitt, S. J., Holmes, G. K., Malkinson, C., Shaheen, M. Z., & Willars, J. E. (1992) · Gut · doi:10.1136/gut.33.7.922 · Cited by 300
Targher, G., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3093 · Cited by 297
Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29121 · Cited by 296
Shinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130722 · Cited by 288
Brouwer, I. A., Zock, P. L., Camm, A. J., Böcker, D., Hauer, R. N. W., Wever, E. F. D., Dullemeijer, C., Ronden, J. E., Katan, M. B., Lubinski, A., et al. (2006) · JAMA · doi:10.1001/jama.295.22.2613 · Cited by 287
Feagan, B. G., Sandborn, W. J., Mittmann, U., Bar-Meir, S., D’Haens, G., Bradette, M., Cohen, A., Dallaire, C., Ponich, T. P., McDonald, J. W. D., et al. (2008) · JAMA · doi:10.1001/jama.299.14.1690 · Cited by 275
n−3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease
The Dry Eye Assessment and Management Study Research Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709691 · Cited by 274
Common purslane: a source of omega-3 fatty acids and antioxidants.
Simopoulos, A. P., Norman, H. A., Gillaspy, J. E., & Duke, J. A. (1992) · Journal of the American College of Nutrition · doi:10.1080/07315724.1992.10718240 · Cited by 267
Omega 3 fatty acids for prevention and treatment of cardiovascular disease
Hooper, L., Harrison, R. A., Summerbell, C. D., Moore, H., Worthington, H. V., Ness, A., Capps, N., Davey Smith, G., Riemersma, R., & Ebrahim, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub2 · Cited by 264
Self-citationEffects of Icosapent Ethyl on Total Ischemic Events
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.032 · Cited by 259
Kremer, J. M., Lawrence, D. A., Petrillo, G. F., Litts, L. L., Mullaly, P. M., Rynes, R. I., Stocker, R. P., Parhami, N., Greenstein, N. S., Fuchs, B. R., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380813 · Cited by 259
Long‐term effect of omega‐3 fatty acid supplementation in active rheumatoid arthritis
Geusens, P., Wouters, C., Nijs, J., Jiang, Y., & Dequeker, J. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370608 · Cited by 258
MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA
Vellas, B., Gillette-Guyonnet, S., Touchon, J., Dantoine, T., Dartigues, J. F., Cuffi, M. N., Bordes, S., Gasnier, Y., Robert, P., Bories, L., et al. (2014) · The Journal Of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2014.34 · Cited by 255
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
Eritsland, J., Arnesen, H., Grønseth, K., Fjeld, N. B., & Abdelnoor, M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89130-8 · Cited by 252
Dodin, S., Lemay, A., Jacques, H., Légaré, F., Forest, J.-C., & Mâsse, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1148 · Cited by 244
Tavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Papanikolaou, Y., Brooks, J., Reider, C., & Fulgoni, V. L. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-31 · Cited by 240
Kuliczkowski, W., Witkowski, A., Polonski, L., Watala, C., Filipiak, K., Budaj, A., Golanski, J., Sitkiewicz, D., Pregowski, J., Gorski, J., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn562 · Cited by 233
de Lorgeril, M., Salen, P., Martin, J.-L., Mamelle, N., Monjaud, I., Touboul, P., & Delaye, J. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00280-x · Cited by 230
Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224
Belch, J. J., Ansell, D., Madhok, R., O'Dowd, A., & Sturrock, R. D. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.2.96 · Cited by 220
(1966) · PubMed · Cited by 218
Relationships between plasma fatty acid composition and coronary artery disease.
Itakura, H., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Kita, T., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5876 · Cited by 218
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.509455 · Cited by 217
Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Dei Cas, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.017 · Cited by 217
Controlled trial of fish oil for regression of human coronary atherosclerosis
Sacks, F. M., Stone, P. H., Gibson, C. M., Silverman, D. I., Rosner, B., & Pasternak, R. C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00095-l · Cited by 216
Bemelmans, W. J., Broer, J., Feskens, E. J., Smit, A. J., Muskiet, F. A., Lefrandt, J. D., Bom, V. J., May, J. F., & Meyboom-de Jong, B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.221 · Cited by 213
Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
Weinstock-Guttman, B., Baier, M., Park, Y., Feichter, J., Lee-Kwen, P., Gallagher, E., Venkatraman, J., Meksawan, K., Deinehert, S., Pendergast, D., et al. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.024 · Cited by 212
Lorenz-Meyer, H., Bauer, P., Nicolay, C., Schulz, B., Purrmann, J., Fleig, W. E., Scheurlen, C., Koop, I., Pudel, V., & Carr, L. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609010352 · Cited by 211
Macsai, M. S. (2008) · PubMed · Cited by 209
Potent Antihypertensive Action of Dietary Flaxseed in Hypertensive Patients
Rodriguez-Leyva, D., Weighell, W., Edel, A. L., LaVallee, R., Dibrov, E., Pinneker, R., Maddaford, T. G., Ramjiawan, B., Aliani, M., Guzman, R., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02094 · Cited by 207
ω-3 Fatty acids: Comparison of plant and seafood sources in human nutrition
Nettleton, J. A. (1991) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)01118-4 · Cited by 207
The ORIGIN Trial Investigators (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.09.009 · Cited by 204
Nilsen, D. W., Albrektsen, G., Landmark, K., Moen, S., Aarsland, T., & Woie, L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.1.50 · Cited by 203
Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis
Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., & Neal, B. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966168 · Cited by 201
Sharp, S. J. (1998) · Stata technical bulletin · Cited by 198
Torjesen, P. A., Birkeland, K. I., Anderssen, S. A., Hjermann, I., Holme, I., & Urdal, P. (1997) · Diabetes Care · doi:10.2337/diacare.20.1.26 · Cited by 198
Effect of dietary α-linolenic acid on thrombotic risk factors in vegetarian men
Li, D., Sinclair, A., Wilson, A., Nakkote, S., Kelly, F., Abedin, L., Mann, N., & Turner, A. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.872 · Cited by 197
Chew, E. Y., Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., & Bernstein, P. S. (2015) · JAMA · doi:10.1001/jama.2015.9677 · Cited by 191
Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis
Kruger, M. C., Coetzer, H., de Winter, R., Gericke, G., & van Papendorp, D. H. (1998) · Aging Clinical and Experimental Research · doi:10.1007/bf03339885 · Cited by 188
Sacks, F. M., Pasternak, R. C., Gibson, C. M., Rosner, B., & Stone, P. H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90506-1 · Cited by 187
Bhatt, D. L., Steg, P. G., Brinton, E. A., Jacobson, T. A., Miller, M., Tardif, J., Ketchum, S. B., Doyle, R. T., Murphy, S. A., Soni, P. N., et al. (2017) · Clinical Cardiology · doi:10.1002/clc.22692 · Cited by 183
Berson, E. L. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.9.1306 · Cited by 183
Galarraga, B., Ho, M., Youssef, H. M., Hill, A., McMahon, H., Hall, C., Ogston, S., Nuki, G., & Belch, J. J. F. (2008) · Rheumatology · doi:10.1093/rheumatology/ken024 · Cited by 183
Violence against pregnant women in developing countries: Review of evidence
Nasir, K. (2003) · The European Journal of Public Health · doi:10.1093/eurpub/13.2.105 · Cited by 183
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, F. O., Ajabnoor, S. M., Deane, K. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012345.pub3 · Cited by 182
Self-citationBates, D., Cartlidge, N. E., French, J. M., Jackson, M. J., Nightingale, S., Shaw, D. A., Smith, S., Woo, E., Hawkins, S. A., & Millar, J. H. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.1.18 · Cited by 181
Byrne, C. D., & Targher, G. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303034 · Cited by 179
Berson, E. L. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.9.1297 · Cited by 175
Matsuzaki, M., Yokoyama, M., Saitō, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1197 · Cited by 166
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, O. F., Ajabnoor, S. M., Deane, K. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012345.pub2 · Cited by 165
Self-citationProudman, S. M., James, M. J., Spargo, L. D., Metcalf, R. G., Sullivan, T. R., Rischmueller, M., Flabouris, K., Wechalekar, M. D., Lee, A. T., & Cleland, L. G. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204145 · Cited by 163
Torkildsen, Ø., Wergeland, S., Bakke, S. J., Beiske, A. G., Bjerve, K. S., Hovdal, H., Midgard, R., Lilleås, F., Pedersen, T., Bjørnarå, B. T., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.283 · Cited by 162
LAU, C. S., MORLEY, K. D., & BELCH, J. J. F. (1993) · Rheumatology · doi:10.1093/rheumatology/32.11.982 · Cited by 161
Tapsell, L. C., Batterham, M. J., Teuss, G., Tan, S.-Y., Dalton, S., Quick, C. J., Gillen, L. J., & Charlton, K. E. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.19 · Cited by 157
Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular Degeneration
Souied, E. H., Delcourt, C., Querques, G., Bassols, A., Merle, B., Zourdani, A., Smith, T., & Benlian, P. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.005 · Cited by 157
Lutein/Zeaxanthin for the Treatment of Age-Related Cataract
Chew, E. Y. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4412 · Cited by 156
Hull, M. A., Sprange, K., Hepburn, T., Tan, W., Shafayat, A., Rees, C. J., Clifford, G., Logan, R. F., Loadman, P. M., Williams, E. A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31775-6 · Cited by 154
Mita, T., Watada, H., Ogihara, T., Nomiyama, T., Ogawa, O., Kinoshita, J., Shimizu, T., Hirose, T., Tanaka, Y., & Kawamori, R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.005 · Cited by 153
Omega-6 fats for the primary and secondary prevention of cardiovascular disease
Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., Ajabnoor, S. M., O'Brien, A. T., Winstanley, L. E., Donaldson, D. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011094.pub3 · Cited by 153
Self-citationOmega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation
Macchia, A., Grancelli, H., Varini, S. D., Nul, D. R., Laffaye, N., Mariani, J. A., Ferrante, D., Badra, R., Figal, J. C., Ramos, S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.021 · Cited by 152
Ramírez-Ramírez, V., Macías-Islas, M. Á., Ortíz, G. G., Pacheco-Moisés, F. P., Torres-Sánchez, E. D., Sorto-Gómez, T. E., Cruz-Ramos, J. A., Orozco-Aviña, G., & de la Rosa, A. D. J. C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/709493 · Cited by 151
Describing reporting guidelines for health research: a systematic review
Moher, D., Weeks, L., Ocampo, M., Seely, D., Sampson, M., Altman, D. G., Schulz, K. F., Miller, D., Simera, I., Grimshaw, J., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.013 · Cited by 151
Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose
Hill, C. L., MARCH, L. M., Aitken, D. A., Lester, S. E., Battersby, R., Hynes, K., Fedorova, T., Proudman, S., James, M. J., Cleland, L. G., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207169 · Cited by 147
The UK Women's Cohort Study: comparison of vegetarians, fish-eaters and meat-eaters
Cade, J. E., Burley, V. J., Greenwood, D. C., & UK Women's Cohort Study Steering Group (2004) · Public Health Nutrition · doi:10.1079/phn2004620 · Cited by 147
Masson, S., Latini, R., Milani, V., Moretti, L., Rossi, M. G., Carbonieri, E., Frisinghelli, A., Minneci, C., Valisi, M., Maggioni, A. P., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.881805 · Cited by 147
Fish, human health and marine ecosystem health: policies in collision
Brunner, E. J., Jones, P. J. S., Friel, S., & Bartley, M. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn157 · Cited by 147
Khan, F., Elherik, K., Bolton-Smith, C., Barr, R., Hill, A., Murrie, I., & Belch, J. J. F. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00395-x · Cited by 145
Caligiuri, S. P. B., Aukema, H. M., Ravandi, A., Guzman, R., Dibrov, E., & Pierce, G. N. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03179 · Cited by 144
Santoro, A., Pini, E., Scurti, M., Palmas, M. G., Berendsen, A. A. M., Brzozowska, A., Pietruszka, B., Szczecińska, A., Cano, N., Meunier, N., et al. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.12.001 · Cited by 144
Dodin, S., Cunnane, S. C., Mâsse, B., Lemay, A., Jacques, H., Asselin, G., Tremblay-Mercier, J., Marc, I., Lamarche, B., Légaré, F., et al. (2008) · Nutrition · doi:10.1016/j.nut.2007.09.003 · Cited by 142
Ethyl-EPA in Huntington disease
Puri, B. K., Leavitt, B. R., Hayden, M. R., Ross, C. A., Rosenblatt, A., Greenamyre, J. T., Hersch, S. M., Vaddadi, K. S., Sword, A., Horrobin, D. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000169025.09670.6d · Cited by 141
Effect of a Fish Oil Diet on Asthma: Results of a 1-Year Double-Blind Study
Dry, J., & Vincent, D. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235421 · Cited by 136
Tuttle, K. R., Shuler, L. A., Packard, D. P., Milton, J. E., Daratha, K. B., Bibus, D. M., & Short, R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.038 · Cited by 134
Omega-6 fats for the primary and secondary prevention of cardiovascular disease
Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., Ajabnoor, S. M., O'Brien, A. T., Winstanley, L. E., Donaldson, D. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011094.pub4 · Cited by 133
Heidt, M. C., Vician, M., Stracke, S., Stadlbauer, T. H. W., Grebe, M., Boening, A., Vogt, P. R., & Erdogan, A. (2009) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0029-1185301 · Cited by 133
Calabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., Bernini, F., & Franceschini, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.007 · Cited by 132
Marchioli, R., Schweiger, C., Tavazzi, L., & Valagussa, F. (2001) · Lipids · doi:10.1007/s11745-001-0694-8 · Cited by 131
Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year
BLOK, W. L., DESLYPERE, J. ‐., DEMACKER, P. N. M., VAN DER VEN‐JONGEKRIJG, J., HECTORS, M. P. C., VAN DER MEER, J. W. M., & KATAN, M. B. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2240775.x · Cited by 129
Burr, M. L., Holliday, R. M., FEHILY, A. M., & WHITEHEAD, P. J. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060141 · Cited by 129
Hjerkinn, E. M., Seljeflot, I., Ellingsen, I., Berstad, P. M., Hjermann, I., Sandvik, L., & Arnesen, H. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.583 · Cited by 128
N-3 fatty acids only delay early relapse of ulcerative colitis in remission
Loeschke, K., Ueberschaer, B., Pietsch, A., Gruber, E., Ewe, K., Wiebecke, B., Heldwein, W., & Lorenz, R. L. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093614 · Cited by 127
Yokoyama, M., & Origasa, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00367-3 · Cited by 127
Marchant, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90103-8 · Cited by 127
Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.029 · Cited by 125
Scorletti, E., West, A. L., Bhatia, L. S., Hoile, S. P., McCormick, K. G., Burdge, G. C., Lillycrop, K. A., Clough, G. F., Calder, P. C., & Byrne, C. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.036 · Cited by 124
Suspected research fraud: difficulties of getting at the truth
White, C. (2005) · BMJ · doi:10.1136/bmj.331.7511.281 · Cited by 124
Bemelmans, W. J. E., Lefrandt, J. D., Feskens, E. J. M., Haelst, P. L. V., Broer, J., Meyboom-de Jong, B., May, J. F., Tervaert, J. W. C., & Smit, A. J. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601938 · Cited by 123
Leaf, D. A., CONNOR, W. E., Barstad, L., & Sexton, G. J. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.68 · Cited by 123
Guyonnet, S., Andrieu, S., DANTOINE, T. F., Dartigues, J., Touchon, J., Vellas, B. J., & MAPT Study Group (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.008 · Cited by 123
Sofi, F., Giangrandi, I., Cesari, F., Corsani, I., Abbate, R., Gensini, G. F., & Casini, A. (2010) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2010.487480 · Cited by 122
Geleijnse, J. M., Giltay, E. J., Schouten, E. G., de Goede, J., Griep, L. M. O., Teitsma-Jansen, A., Katan, M., & Kromhout, D. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.12.033 · Cited by 121
Brouwer, I. A., Raitt, M. H., Dullemeijer, C., Kraemer, D. F., Zock, P. L., Morris, C., Katan, M. B., Connor, W. E., Camm, J. A., Schouten, E. G., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp003 · Cited by 120
Kromhout, D., Geleijnse, J. M., de Goede, J., Griep, L. M. O., Mulder, B. J. M., de Boer, M., Deckers, J. W., Boersma, E. H., Zock, P. L., & Giltay, E. J. (2011) · Diabetes Care · doi:10.2337/dc11-0896 · Cited by 119
Tomer, A., Kasey, S., Connor, W., Clark, S., Harker, L. A., & Eckman, J. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615948 · Cited by 118
Bonds, D. E., Harrington, M., Worrall, B. B., Bertoni, A. G., Eaton, C. B., Hsia, J., Robinson, J., Clemons, T. E., Fine, L. J., & Chew, E. Y. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.328 · Cited by 118
Scott, C. B., Littlefield, N. D., Chason, J. D., Bunker, M. P., & Asselin, E. M. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-1 · Cited by 118
Mariani, J. A., Doval, H. C., Nul, D. R., Varini, S. D., Grancelli, H., Ferrante, D., Tognoni, G., & Macchia, A. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.005033 · Cited by 117
on behalf of The SUPERIOR SVG Study Investigators, Deb, S., Singh, S. K., de Souza, D., Chu, M. W. A., Whitlock, R. P., Meyer, S. R., Verma, S., Jeppsson, A., Al-Saleh, A., et al. (2019) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-019-0887-x · Cited by 117
Circulating Omega-3 Fatty Acids and Neovascular Age-Related Macular Degeneration
Merle, B. M. J., Benlian, P., Puche, N., Bassols, A., Delcourt, C., & Souied, E. H. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-13916 · Cited by 113
Deane, K. H., Jimoh, F. O., Biswas, P., O'Brien, A. T., Hanson, S., Abdelhamid, A. S., Fox, C., & Hooper, L. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.234 · Cited by 113
Self-citationWhelton, P., Kumanyika, S., Cook, N. R., Cutler, J., Borhani, N., Hennekens, C. H., Kuller, L. H., Langford, H. G., Jones, D., Satterfield, S., et al. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.652s · Cited by 112
Ness, A., Hughes, J., Elwood, P., Whitley, E., Smith, G., & Burr, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601342 · Cited by 111
Geleijnse, J. M., Giltay, E. J., & Kromhout, D. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.06.002 · Cited by 111
Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Cas, L. D. (2011) · Circulation · doi:10.1161/circulationaha.111.022194 · Cited by 111
Dawczynski, J., Jentsch, S., Schweitzer, D., Hammer, M., Lang, G. E., & Strobel, J. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2376-6 · Cited by 108
Eritsland, J., Arnesen, H., Seljeflot, I., & Kierulf, P. (1995) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199502000-00003 · Cited by 107
Sanders, T. A. B., Hall, W. L., Maniou, Z., Lewis, F., Seed, P. T., & Chowienczyk, P. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018036 · Cited by 107
Edel, A. L., Rodriguez-Leyva, D., Maddaford, T. G., Caligiuri, S. P., Austria, J. A., Weighell, W., Guzman, R., Aliani, M., & Pierce, G. N. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.204594 · Cited by 106
Hjerkinn, E. M., Abdelnoor, M., Breivik, L., Bergengen, L., Ellingsen, I., Seljeflot, I., Aase, O., Klemsdal, T. O., Hjermann, I., & Arnesen, H. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000209817.28444.fb · Cited by 106
EICOSAPENTAENOIC ACID AND IgA NEPHROPATHY
Hamazaki, T., Tateno, S., & Shishido, H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92355-9 · Cited by 105
Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., & Hirayama, T. (1999) · Lipids · doi:10.1007/bf02562338 · Cited by 105
Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)
Bassuk, S. S., Manson, J. E., Lee, I.-M. M., Cook, N. R., Christen, W. G., Bubes, V. Y., Gordon, D., Copeland, T., Friedenberg, G., D’Agostino, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.12.022 · Cited by 102
NEUROPSYCHOLOGICAL PROFILE OF “COGNITIVE FRAILTY” SUBJECTS IN MAPT STUDY
Delrieu, J., Andrieu, S., Pahor, M., Cantet, C., Cesari, M., Ousset, P., Voisin, T., Fougère, B., Guyonnet, S., Carrié, I., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.94 · Cited by 102
Al‐Hilal, M., AlSaleh, A. F. F., Maniou, Z., Lewis, F. J., Hall, W. L., Sanders, T. A. B., & O’Dell, S. D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p032276 · Cited by 101
Alfaddagh, A., Elajami, T. K., Ashfaque, H., Saleh, M. A., Bistrian, B. R., & Welty, F. K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006981 · Cited by 101
Einvik, G., Klemsdal, T. O., Sandvik, L., & Hjerkinn, E. M. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328339cc70 · Cited by 100
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial
Maggioni, A. P., Fabbri, G., Lucci, D., Marchioli, R., Franzosi, M. G., Latini, R., Nicolosi, G. L., Porcu, M., Cosmi, F., Stefanelli, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp357 · Cited by 100
Walker, C. G., Browning, L. M., Mander, A., Madden, J., West, A. L., Calder, P. C., & Jebb, S. A. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002985 · Cited by 100
Eussen, S. R. B. M., Geleijnse, J. M., Giltay, E. J., Rompelberg, C. J. M., Klungel, O. H., & Kromhout, D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr499 · Cited by 99
Fehér, J., Kovàcs, B., Kovács, I., Schveoller, M., Papale, A., & Gabrieli, C. B. (2005) · Ophthalmologica · doi:10.1159/000085248 · Cited by 99
Zhang, Y.-P., Miao, R., Li, Q., Wu, T., & Ma, F. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160439 · Cited by 99
Andreeva, V. A., Kesse‐Guyot, E., Barberger‐Gateau, P., Fezeu, L., Herçberg, S., & Galan, P. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.006320 · Cited by 97
Fish Oil for the Reduction of Atrial Fibrillation Recurrence, Inflammation, and Oxidative Stress
Nigam, A., Talajic, M. R., Roy, D., Nattel, S., Lambert, J., Nozza, A., Jones, P. J. H., Ramprasath, V. R., O’Hara, G. E., Kopecky, S. L., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.956 · Cited by 96
Walker, C. G., West, A. L., Browning, L. M., Madden, J., Gambell, J., Jebb, S. A., & Calder, P. C. (2015) · Nutrients · doi:10.3390/nu7085285 · Cited by 95
Angerer, P., Kothny, W., Störk, S., & von Schacky, C. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00229-8 · Cited by 95
Zhao, Y.-T., Chen, Q., Sun, Y.-X., Li, X.-B., Zhang, P., Xu, Y., & Guo, J.-H. (2009) · Annals of Medicine · doi:10.1080/07853890802698834 · Cited by 94
Dangour, A. D., Allen, E., Elbourne, D. R., FLETCHER, A. E., Richards, M., & Uauy, R. D. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0057-2 · Cited by 92
Research works printed but not linked: 83
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Brouwer, 2013, Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial, PLOS ONE, 8, e81519, 10.1371/journal.pone.0081519 · DOI
- Eussen, 2012, Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction, European Heart Journal, 33, 1582, 10.1093/eurheartj/ehr499 · DOI
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: A randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 8, 278, 10.1016/j.jalz.2011.06.002 · DOI
- Geleijnse, 2010, Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial, American Heart Journal, 159, 539, 10.1016/j.ahj.2009.12.033 · DOI
- Giltay, 2012, No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial, International Journal of Andrology, 35, 680, 10.1111/j.1365-2605.2012.01255.x · DOI
- Giltay, 2011, Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction, American Journal of Clinical Nutrition, 94, 1442, 10.3945/ajcn.111.018259 · DOI
- Hoogeveen, 2012, Effects of N-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega Trial, Nephrology Dialysis Transplantation, 27, ii64
- Hoogeveen, 2014, No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial, European Journal of Preventive Cardiology, 21, 1429, 10.1177/2047487313494295 · DOI
- Hoogeveen, 2014, Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial, Clinical Journal of The American Society of Nephrology: CJASN, 9, 1676, 10.2215/CJN.10441013 · DOI
- Kromhout, 2011, N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in post myocardial infarction patients with diabetes, Diabetes Care, 34, 2515, 10.2337/dc11-0896 · DOI
- Kromhout, 2010, N-3 fatty acids and cardiovascular events after myocardial infarction, New England Journal of Medicine, 363, 2015, 10.1056/NEJMoa1003603 · DOI · Paper page
- Burr, 1989, Fish and the heart, Lancet, ii, 1451
- Harrison, 2005, Dietary Intervention for Maintaining Sinus Rhythm Following Cardioversion for Atrial Fibrillation: a Randomised Controlled Trial [PhD thesis]
- Harrison, 2003, Using community-based dietary assistants to increase the intake of oil-rich fish among older people, European Journal of Public Health, 13, 105
- Doi, 2014, Clinical outcomes of early initiation of pure eicosapentaenoic acid supplement after percutaneous coronary intervention in patients with acute coronary syndrome, European Heart Journal, 35, 1156
- Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials, JAMA, 229, 1690, 10.1001/jama.299.14.1690 · DOI · Paper page
- Erdogan, 2007, Omega AF study: polyunsaturated fatty acids (PUFA) for prevention of atrial fibrillation relapse after successful external cardioversion, Heart Rhythm, 4, S185
- Edel, 2013, Flaxseed lignan metabolites elicit antihypertensive effects in pad patients in the flax-pad trial, Annals of Nutrition and Metabolism, 63, 1339
- Pierce, 2014, The use of dietary flaxseed to promote cardiovascular health, Acta Physiologica, 211, 15
- Pierce, 2013, The clinical use of flaxseed as a powerful nutritional intervention to treat cardiovascular disease, Cardiology (Switzerland), 126, 201
- Gill, 2014, Omega-3 fatty acids effects on carotid IMT in metabolic syndrome, Circulation, 130, A1269. Abstract
- Finzi, 2009, Antiarrhythmic effects of n-3 PUFA in patients with heart failure and an implantable cardioverter defibrillator in the GISSI-HF trial, European Heart Journal, 30, 279
- Rovere, 2011, Effect of n-3PUFA on heart rate variability. Data from the GISSI-HF holter substudy, Circulation, 124, A14829
- Latini, 2011, Circulating levels of n-3 polyunsaturated fatty acids in patients with chronic heart failure. Data from the GISSI-HF trial, European Heart Journal, 32, 919
- Marchioli, 2009, Time course analysis of the effect of n-3 PUFA on fatal and non fatal arrhythmias in heart failure: secondary results of the GISSI-HF trial, European Heart Journal, 30, 165
- Marchioli, 2009, Time course analysis of the effect of n-3 PUFA on fatal and non fatal heart failure: secondary results of the GISSI-HF trial, European Heart Journal, 30, 432
- Marchioli, 2009, Prognostic ability of a Mediterranean dietary score in heart failure: preliminary analysis of the GISSI-Heart failure Trial, European Heart Journal, 30, 1026
- Marchioli, 2009, Effect of n-3 PUFA in heart failure patients with different dietary habits: preliminary results of the GISSI-heart failure trial, European Heart Journal, 30, 426
- Marchioli, 2009, Effect of n-3 PUFA according to fish intake: preliminary results of GISSI-Heart Failure, European Heart Journal, 30, 707
- Tan, 2010, Dietary Manipulation and Weight Management [PhD thesis]
- Delrieu, 2011, Multidomain alzheimer's disease preventive trial: florbetapir ancillary study, Alzheimer's and Dementia, 1, S419, 10.1016/j.jalz.2011.05.1217 · DOI
- Gillette, 2009, The multidomain Alzheimer preventive trial (MAPT): a new approach for the prevention of Alzheimer's disease, Alzheimer's & Dementia, S4-02-05, 145, 10.1016/j.jalz.2009.05.496 · DOI
- Gillette-Guyonnet, 2011, MAPT study: a 3-year randomized trial of omega 3 and/or multidomain intervention for the prevention of cognitive decline in frail elderly subjects-rationale, design and baseline data, Alzheimer's & Dementia, 1, S97
- Vellas, 2012, MAPT (multidomain Alzheimer preventive trial) imaging (MRI, FDG-PET, amyloid-PET) data, Journal of Nutrition, Health and Aging, 16, 812
- Pinto, 2015, Effect of low doses of long chain n-3 PUFA intake on daytime heart rate variability: results from the MARINA study, European Journal of Preventive Cardiology, 1, S146
- Nodari, 2010, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in heart failure patients, European Heart Journal, 31, 850
- Nodari, 2012, Plasma levels of n-3 polyunsaturated fatty acids and risk of hospitalization in patients with non-ischemic cardiomyopathy, Circulation. Conference: American Heart Association, 126, A17431
- Ilsey, 1987, Randomised placebo controlled trial of MAXEPA and aspirin/persantin after successful coronary angioplasty, Australian & New Zealand Journal of Medicine, 17, 559
- Naesgaard, 2014, The effect on vitamin D levels of long-term high-dose treatment with a concentrated omega-3 compound (Omacor/Lovaza) in patients hospitalized with a myocardial infarction, Circulation, 130, A17245
- Poenitz, 2012, Pentraxin 3 is uninfluenced by high doses of concentrated omega-3 fatty acids administered for 12 months following an acute myocardial infarction, Circulation. Conference: American Heart Association, 126, A13464
- Bordeleau, 2013, Cancer outcomes in patients with dysglycemia on basal insulin: results of the Origin trial, Diabetes, 62, A72
- Proudman, 2012, Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose, Internal Medicine Journal, 42, 2
- Eritsland, 1994, Effect of supplementation with n-3 fatty acids on graft patency in patients undergoing coronary artery bypass operation. Results from SHOT study, European Heart Journal, 15, 29
- Eritsland, 1993, Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids, Thrombosis and Haemostasis, 69, 1065
- Galan, 2008, The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics, Trials, 9, 35, 10.1186/1745-6215-9-35 · DOI
- Galan, 2009, The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega3 fatty acid supplements in the prevention of recurrent ischemic events, Sang Thrombose Vaisseaux, 21, 207
- Galan, 2009, The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega3 fatty acid supplements in the prevention of recurrent ischemic events, Sang Thrombose Vaisseaux, 21, 207
- McCormick, 2015, Peripheral sensory nerve function is independently associated with microvascular function, but neither are improved by n-3 fatty acids, Diabetic Medicine, 32, 99
- Scorletti, 2014, Potential benefits of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease (NAFLD): a potential treatment for early NAFLD in metabolic syndrome and type 2 diabetes? Results from the WELCOME study, Diabetic Medicine, 31, 1
- Baleztena Gurrea, 2015, Utility of heavy food supplement in omega-3 fatty acids in the prevention of dementia, in relation to the basal nutritional level, in people of advanced age: randomized multicenter study, Revista Española de Geriatría y Gerontología, 50, 1
- Bes-Rastrollo, 2015, Utility of a rich food supplement Omega-3 fatty acids in the prevention of dementia, in relation to baseline nutritional level, in people with advanced age: multicentre randomised study, Nutrición Clínica en Medicina, 9, 38
- Cheng, 1990, The effect of omega-3 fatty acids on restenosis after coronary angioplasty, European Heart Journal, 11, 368
- Fonolla, 2011, Daily intake of a low lactose dairy drink enriched with omega-3 (EPA+DHA), oleic acid and calcium improves nutritional and bone status in healthy postmenopausal women, Clinical Nutrition, 6, 86
- Franzen, 1989, Long-term effect of fish oil and olive oil on plasma lipids in patients with CHD, Zeitschrift fur Kardiologie, 78, 28
- Gapparova, 2000, Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance, Voprosy Pitaniia, 69, 46
- Hashimoto, 2011, Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function in elderly people with very mild dementia in Japan, Alzheimer's and Dementia, 1, S610
- Hashimoto, 2012, Beneficial effects of daily dietary omega-3 polyunsaturated fatty acid supplementation on age related cognitive decline in elderly Japanese with very mild dementia: a 2-year randomized,double-blind, placebo-controlled trial, Journal of Aging Research & Clinical Practice, 1, 193
- Lau, 1991, Effects of Maxepa on non-steroidal anti-inflammatory drug useage in patients with mild rheumatoid arthritis, British Journal of Rheumatology, 30, 137
- Lorgeril, 1999, Does a Mediterranean dietary pattern prolong survival?, Cardiology Review, 16, 30
- Mantzaris, 1996, A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis, Hellenic Journal of Gastroenterology, 9, 138
- Mate, 1991, Does dietary fish oil maintain the remission of Crohn's disease: a study case control, Gastroenterology, 100, A228
- Colquhoun, 1997, Rationale and design of the "OLIVE" study (comparison of an olive oil enriched to a low fat diet intervention study using vascular endpoints), Atheroscerosis, 134, 326
- Colquhoun, 1998, Comparison of an olive oil enriched diet to a low fat diet intervention study using vascular endpoints: assessed by repeat quantitative angiography (OLIVE study), Australian Journal of Nutrition and Dietetics, 55, S24
- Meilahn, 1990, Coagulation parameters among healthy adults taking fish oil versus placebo, Arteriosclerosis, 10, 916A
- Singh, 2012, Effect of low W-6/W-3 fatty acid ratio Paleolithic style diet in patients with acute coronary syndromes: a randomized, single blind, controlled trial, World Heart Journal, 4, 71
- Singh, 1997, Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4, Cardiovascular Drugs and Therapy, 11, 485, 10.1023/A:1007757724505 · DOI · Paper page
- Bowman, 2012, ASCEND: design and baseline characteristics of a large randomised trial in diabetes, Diabetes, 61, A556
- Chandrakala, 2012, Low-fat (< 20%) diets prevent type 2 diabetes mellitus, Diabetes, 61, A190
- Laake, 2014, Effects of omega 3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study, BMC Geriatrics, 14, 74, 10.1186/1471-2318-14-74 · DOI
- Shinto, 2015, Omega 3 fatty acids for the prevention of vascular cognitive aging: methods and rationale for a phase II trial, Alzheimer's & Dementia, 11, 610, 10.1016/j.jalz.2015.06.847 · DOI
- Gold, 2014, Baseline chronic obstructive pulmonary disease in the lung vitamin D and omega-3 trial, American Journal of Respiratory and Critical Care Medicine, 189, D44 COPD
- Kang, 2015, Cognitive substudy of the vitamin d and omega-3 trial (vital-cog): design of a large randomized trial of omega-3 and vitamin d supplements in relation to cognitive change, Alzheimer's & Dementia, 1, 608, 10.1016/j.jalz.2015.06.843 · DOI
- Manson, 2010, Vitamin D and cancer and cardiovascular disease: ready for prime time?, Menopause, 17, 1215
- Abdelhamid, 2017, Polyunsaturated fatty acids for musculoskeletal health and functional status in older adults, PROSPERO, www.crd.york.ac, CRD42017079211
- Hanson, 2017, Dietary polyunsaturated fat for prevention and treatment of depression and anxiety, PROSPERO, www.crd.york.ac, CRD42017056092
- Higgins JP Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Jimoh, 2017, Dietary polyunsaturated fat for prevention and treatment of neurocognitive disorders, PROSPERO, www.crd.york.ac, CRD42017019049
- Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Liem, 1997, Dioxins: Chemical Analysis, Exposure and Risk Assessment
- Mariani, 2013, N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials, Journal of the American Heart Association, 2, e005033, 10.1161/JAHA.112.005033 · DOI
- Thorpe, 2017, Dietary polyunsaturated fat for prevention and treatment of inflammatory bowel disease, PROSPERO, www.crd.york.ac, CRD42017068704
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Metadata
- Authors
- Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., Song, F., & Hooper, L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-07-18
- Volume
- 3
- Pages
- CD003177-CD003177
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2884415415
- Cited by
- 630
- References
- 483
- FWCI
- 65.32
- Type
- journal article
- Language
- en
- Update notices
- new_version (2018-11-30)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.